(1->4)-beta-D-glucan multiple interactions ISO RGD:1320143 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of P4HA2 mRNA CTD PMID:36331819 1,10-phenanthroline increases expression ISO RGD:1320142 6480464 1, 10-phenanthroline results in increased expression of P4HA2 mRNA CTD PMID:19502547 1,2-dichloroethane increases expression ISO RGD:1320143 6480464 ethylene dichloride results in increased expression of P4HA2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:1320143 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of P4HA2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:1320143 6480464 Ethinyl Estradiol affects the expression of P4HA2 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1320143 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of P4HA2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1320143 6480464 Ethinyl Estradiol results in increased expression of P4HA2 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1320142 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of P4HA2 mRNA, [Estradiol co-treated with TGFB1 protein] results in increased expression of P4HA2 mRNA CTD PMID:19619570 , PMID:30165855 17beta-estradiol increases expression ISO RGD:1320142 6480464 Estradiol results in increased expression of P4HA2 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1320142 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of P4HA2 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of P4HA2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1320143 6480464 Tetrachlorodibenzodioxin results in increased expression of P4HA2 mRNA CTD PMID:17942748 , PMID:27562557 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1320143 6480464 Tetrachlorodibenzodioxin affects the expression of P4HA2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of P4HA2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1320143 6480464 Tetrachlorodibenzodioxin results in decreased expression of P4HA2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1320143 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of P4HA2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1320142 6480464 Tetrachlorodibenzodioxin results in increased expression of P4HA2 mRNA CTD PMID:19619570 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of P4HA2 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of P4HA2 mRNA CTD PMID:21346803 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1320143 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of P4HA2 mRNA CTD PMID:26251327 4,4'-sulfonyldiphenol increases expression ISO RGD:1320143 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of P4HA2 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO RGD:1320142 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of P4HA2 protein CTD PMID:34186270 4,4'-sulfonyldiphenol affects expression ISO RGD:1320142 6480464 bis(4-hydroxyphenyl)sulfone affects the expression of P4HA2 protein CTD PMID:31945527 5-aza-2'-deoxycytidine increases expression ISO RGD:1320142 6480464 Decitabine results in increased expression of P4HA2 mRNA CTD PMID:19194470 5-aza-2'-deoxycytidine affects expression ISO RGD:1320142 6480464 Decitabine affects the expression of P4HA2 mRNA CTD PMID:23300844 5-chloro-7-iodoquinolin-8-ol decreases expression ISO RGD:1320142 6480464 Clioquinol results in decreased expression of P4HA2 mRNA CTD PMID:19502547 acrylamide increases expression ISO RGD:1320142 6480464 Acrylamide results in increased expression of P4HA2 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:1320142 6480464 Aflatoxin B1 results in increased expression of P4HA2 mRNA CTD PMID:21641981 all-trans-retinoic acid increases expression ISO RGD:1320142 6480464 Tretinoin results in increased expression of P4HA2 mRNA CTD PMID:17138961 atrazine increases expression ISO RGD:1320142 6480464 Atrazine results in increased expression of P4HA2 mRNA CTD PMID:22378314 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of P4HA2 gene CTD PMID:35440735 benzo[a]pyrene increases expression ISO RGD:1320142 6480464 Benzo(a)pyrene results in increased expression of P4HA2 mRNA CTD PMID:22316170 benzo[a]pyrene increases methylation ISO RGD:1320142 6480464 Benzo(a)pyrene results in increased methylation of P4HA2 promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1320142 6480464 Benzo(a)pyrene results in decreased methylation of P4HA2 5' UTR CTD PMID:27901495 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1320142 6480464 Diethylhexyl Phthalate results in increased expression of P4HA2 mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1320142 6480464 Diethylhexyl Phthalate results in decreased expression of P4HA2 protein CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of P4HA2 mRNA CTD PMID:25181051 , PMID:32145629 bisphenol A decreases expression ISO RGD:1320142 6480464 bisphenol A results in decreased expression of P4HA2 protein CTD PMID:34186270 bisphenol A affects expression ISO RGD:1320142 6480464 bisphenol A affects the expression of P4HA2 mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1320143 6480464 bisphenol A results in increased expression of P4HA2 mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of P4HA2 gene CTD PMID:28505145 Bisphenol B increases expression ISO RGD:1320142 6480464 bisphenol B results in increased expression of P4HA2 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1320143 6480464 bisphenol F results in increased expression of P4HA2 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:1320142 6480464 bisphenol F results in increased expression of P4HA2 protein CTD PMID:34186270 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of P4HA2 mRNA CTD PMID:33453195 cadmium dichloride decreases expression ISO RGD:1320142 6480464 Cadmium Chloride results in decreased expression of P4HA2 mRNA CTD PMID:26472689 calciol increases expression ISO RGD:1320143 6480464 Cholecalciferol results in increased expression of P4HA2 mRNA CTD PMID:17170073 calcium silicate decreases expression ISO RGD:1320143 6480464 calcium silicate results in decreased expression of P4HA2 mRNA CTD PMID:29279043 carbon nanotube increases expression ISO RGD:1320143 6480464 Nanotubes, Carbon results in increased expression of P4HA2 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1320142 6480464 CGP 52608 promotes the reaction [RORA protein binds to P4HA2 gene] CTD PMID:28238834 choline multiple interactions ISO RGD:1320143 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of P4HA2 mRNA CTD PMID:20938992 cisplatin decreases response to substance ISO RGD:1320142 6480464 P4HA2 protein results in decreased susceptibility to Cisplatin CTD PMID:16734730 cisplatin multiple interactions ISO RGD:1320142 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of P4HA2 mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:1320142 6480464 Cisplatin results in increased expression of P4HA2 mRNA CTD PMID:27392435 cisplatin affects expression ISO RGD:1320142 6480464 Cisplatin affects the expression of P4HA2 mRNA CTD PMID:23300844 cobalt dichloride multiple interactions ISO RGD:1320142 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of P4HA2 mRNA] CTD PMID:22202117 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of P4HA2 mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:1320142 6480464 cobaltous chloride results in increased expression of P4HA2 mRNA CTD PMID:19320972 more ... cyclosporin A increases expression ISO RGD:1320142 6480464 Cyclosporine results in increased expression of P4HA2 mRNA CTD PMID:20106945 , PMID:25562108 cytarabine decreases expression ISO RGD:1320142 6480464 Cytarabine results in decreased expression of P4HA2 mRNA CTD PMID:21198554 dexamethasone decreases expression ISO RGD:1320142 6480464 Dexamethasone results in decreased expression of P4HA2 mRNA CTD PMID:25047013 diclofenac increases expression ISO RGD:1320142 6480464 Diclofenac results in increased expression of P4HA2 mRNA CTD PMID:17379860 dioxygen increases expression ISO RGD:1320143 6480464 Oxygen deficiency results in increased expression of P4HA2 mRNA CTD PMID:20880076 dioxygen increases expression ISO RGD:1320142 6480464 Oxygen deficiency results in increased expression of P4HA2 mRNA CTD PMID:19502547 more ... dioxygen multiple interactions ISO RGD:1320142 6480464 HIF1A mutant form inhibits the reaction [Oxygen deficiency results in increased expression of P4HA2 mRNA] CTD PMID:23423382 dioxygen multiple interactions ISO RGD:1320143 6480464 HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of P4HA2 mRNA] CTD PMID:20880076 diquat increases expression ISO RGD:1320143 6480464 Diquat results in increased expression of P4HA2 mRNA CTD PMID:36851058 dorsomorphin multiple interactions ISO RGD:1320142 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 entinostat increases expression ISO RGD:1320142 6480464 entinostat results in increased expression of P4HA2 mRNA CTD PMID:26272509 , PMID:27188386 entinostat multiple interactions ISO RGD:1320142 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of P4HA2 mRNA CTD PMID:27188386 ethanol multiple interactions ISO RGD:1320142 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of P4HA2 mRNA CTD PMID:23378141 ethanol decreases expression ISO RGD:1320143 6480464 Ethanol results in decreased expression of P4HA2 mRNA CTD PMID:34755883 ethanol increases expression ISO RGD:1320142 6480464 Ethanol results in increased expression of P4HA2 mRNA CTD PMID:28986285 fluoranthene multiple interactions ISO RGD:1320143 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of P4HA2 mRNA CTD PMID:28329830 folic acid multiple interactions ISO RGD:1320143 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folic acid multiple interactions ISO RGD:1320142 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of P4HA2 mRNA CTD PMID:23378141 ivermectin decreases expression ISO RGD:1320142 6480464 Ivermectin results in decreased expression of P4HA2 protein CTD PMID:32959892 L-ascorbic acid decreases expression ISO RGD:1320142 6480464 Ascorbic Acid results in decreased expression of P4HA2 mRNA CTD PMID:19197388 L-methionine multiple interactions ISO RGD:1320143 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of P4HA2 mRNA CTD PMID:20938992 lead(0) affects expression ISO RGD:1320142 6480464 Lead affects the expression of P4HA2 mRNA CTD PMID:28903495 methamphetamine multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of P4HA2 mRNA CTD PMID:19564919 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of P4HA2 mRNA CTD PMID:19564919 nickel dichloride multiple interactions ISO RGD:1320143 6480464 HIF1A affects the reaction [nickel chloride results in increased expression of P4HA2 mRNA] CTD PMID:12426141 , PMID:12729255 nickel dichloride increases expression ISO RGD:1320143 6480464 nickel chloride results in increased expression of P4HA2 mRNA CTD PMID:12426141 more ... nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of P4HA2 mRNA CTD PMID:22110744 nickel subsulfide affects expression ISO RGD:1320143 6480464 nickel subsulfide affects the expression of P4HA2 mRNA CTD PMID:12729255 nickel sulfate increases expression ISO RGD:1320142 6480464 nickel sulfate results in increased expression of P4HA2 mRNA CTD PMID:17382205 oxaliplatin decreases expression ISO RGD:1320142 6480464 oxaliplatin results in decreased expression of P4HA2 mRNA CTD PMID:17762391 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of P4HA2 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1320143 6480464 Acetaminophen affects the expression of P4HA2 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of P4HA2 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1320142 6480464 Acetaminophen results in increased expression of P4HA2 mRNA CTD PMID:22230336 , PMID:29067470 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1320143 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of P4HA2 mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO RGD:1320142 6480464 perfluorooctanoic acid results in decreased expression of P4HA2 protein CTD PMID:26879310 phenobarbital multiple interactions ISO RGD:1320143 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of P4HA2 mRNA] CTD PMID:19482888 phenobarbital increases expression ISO RGD:1320143 6480464 Phenobarbital results in increased expression of P4HA2 mRNA CTD PMID:19482888 phenylmercury acetate multiple interactions ISO RGD:1320142 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of P4HA2 mRNA CTD PMID:27188386 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of P4HA2 protein CTD PMID:18563748 progesterone affects expression ISO RGD:1320143 6480464 Progesterone affects the expression of P4HA2 mRNA CTD PMID:17251523 propiconazole increases expression ISO RGD:1320143 6480464 propiconazole results in increased expression of P4HA2 mRNA CTD PMID:21278054 SB 431542 multiple interactions ISO RGD:1320142 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SCH 23390 multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of P4HA2 mRNA CTD PMID:19564919 SCH 23390 increases expression EXP 6480464 SCH 23390 results in increased expression of P4HA2 mRNA CTD PMID:19564919 serpentine asbestos increases methylation ISO RGD:1320142 6480464 Asbestos, Serpentine results in increased methylation of P4HA2 5' UTR CTD PMID:29523930 sodium arsenite increases expression ISO RGD:1320142 6480464 sodium arsenite results in increased expression of P4HA2 mRNA CTD PMID:24516582 sunitinib increases expression ISO RGD:1320142 6480464 Sunitinib results in increased expression of P4HA2 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1320143 6480464 Tamoxifen affects the expression of P4HA2 mRNA CTD PMID:17555576 temozolomide decreases expression ISO RGD:1320142 6480464 Temozolomide results in decreased expression of P4HA2 mRNA CTD PMID:31758290 tetrachloromethane affects expression ISO RGD:1320143 6480464 Carbon Tetrachloride affects the expression of P4HA2 mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of P4HA2 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1320143 6480464 Carbon Tetrachloride results in increased expression of P4HA2 mRNA CTD PMID:27339419 , PMID:31919559 thifluzamide increases expression ISO RGD:1320142 6480464 thifluzamide results in increased expression of P4HA2 mRNA CTD PMID:33512557 titanium dioxide increases expression ISO RGD:1320143 6480464 titanium dioxide results in increased expression of P4HA2 mRNA CTD PMID:27760801 titanium dioxide decreases expression ISO RGD:1320143 6480464 titanium dioxide results in decreased expression of P4HA2 mRNA CTD PMID:29264374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of P4HA2 mRNA CTD PMID:25729387 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of P4HA2 gene CTD PMID:27618143 trichostatin A increases expression ISO RGD:1320142 6480464 trichostatin A results in increased expression of P4HA2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1320142 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of P4HA2 mRNA CTD PMID:27188386 triptonide decreases expression ISO RGD:1320143 6480464 triptonide results in decreased expression of P4HA2 mRNA CTD PMID:33045310 valproic acid affects expression ISO RGD:1320142 6480464 Valproic Acid affects the expression of P4HA2 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1320142 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of P4HA2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1320142 6480464 Valproic Acid results in increased expression of P4HA2 mRNA CTD PMID:23179753 more ... valproic acid increases methylation ISO RGD:1320142 6480464 Valproic Acid results in increased methylation of P4HA2 gene CTD PMID:29154799 vancomycin decreases expression ISO RGD:1320143 6480464 Vancomycin results in decreased expression of P4HA2 mRNA CTD PMID:18930951 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of P4HA2 mRNA CTD PMID:23034163 zinc atom multiple interactions ISO RGD:1320142 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of P4HA2 mRNA CTD PMID:18593933 zinc dichloride multiple interactions ISO RGD:1320142 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of P4HA2 mRNA] CTD PMID:22202117 zinc(0) multiple interactions ISO RGD:1320142 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of P4HA2 mRNA CTD PMID:18593933 zoledronic acid increases expression ISO RGD:1320142 6480464 zoledronic acid results in increased expression of P4HA2 mRNA CTD PMID:24714768